Universiteit Gent

Bangor University

Seppe Vander-Beken

Mark Stephen Baird

Johan Adriaan Marc Grooten

Gani Koza

Cornelias Theunissen

Juma′ A Raheem Najeem Al-Dulayy-mi

A compound of formula (I) for use in the treatment of a disease of the immune system; wherein R is an optionally-substituted alkyl, alkenyl, alkynyl, aryl, arylalkyl or alkylaryl moiety having from 1 to 50 carbon atoms; Ris an optionally-substituted alkyl, alkenyl, alkynyl, aryl, arylalkyl or alkylaryl moiety having from 1 to 40 carbon atoms; each of R, Rand Ris independently selected from an optionally-substituted alkylene, alkenylene, alkynylene, arylene, arylalkylene or alkylarylene moiety having from 1 to 40 carbon atoms; each of X, Y and Z is independently selected from an optionally-substituted alkylene, alkenylene, alkenylene, arylene, alkylarylene, cycloalkylene, ketone, ester, amide, imide, imine, thioether, ether, thioester and thioketone; and P is selected from hydrogen, an alkyl group, a sugar residue, or a metal, phosphonium or ammonium species; wherein at least one of X, Y and Z includes a moiety selected from cyclopropyl, C=A, C-AH and C&#x2014;OR; wherein Ris alkyl or haloalkyl, and A is O, S or NR, wherein Rmay be H or 20 alkyl. 

Growing community of inventors

Ghent, Belgium

Seppe Vander-Beken